Prognostic significance of preoperative lymphocytes, albumin, and neutrophils (LANR) index in resectable pancreatic ductal adenocarcinoma

被引:3
作者
Zhuang, Jiaru [1 ]
Wang, Shan [2 ]
Wang, Yuan [2 ]
Wu, Yibo [2 ]
Hu, Renjing [1 ]
机构
[1] Jiangnan Univ, Med Ctr, Wuxi No Peoples Hosp, Dept Lab Med, 68 Zhongshan Rd, Wuxi 214000, Jiangsu, Peoples R China
[2] Jiangnan Univ, Affiliated Hosp, Human Reprod & Genet Ctr, 1000 Hefeng Rd, Wuxi 214000, Jiangsu, Peoples R China
关键词
Pancreatic ductal adenocarcinoma; LANR; Biomarker; Prognosis; Survival; SERUM-ALBUMIN; INFLAMMATORY MARKERS; CANCER; SURVIVAL; LEVEL; HEAD;
D O I
10.1186/s12885-024-12329-z
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose The index composed of preoperative lymphocytes, albumin, and neutrophils (LANR), a new composite score based on inflammatory response and nutritional status, has been reported to be associated with the prognosis of multiple types of cancer, but the role of LANR in the prognosis of resectable pancreatic ductal adenocarcinoma (PDAC) has not yet been elucidated. Patients and methods The data of 142 patients with PDAC who underwent radical resection in the Affiliated Hospital of Jiangnan University from January 2015 to December 2018 were retrospectively analyzed. Receiver Operating Characteristic (ROC) curves were generated to determine the optimal cut-off values for these parameters, as well as the sensitivity and specificity of LANR in predicting survival. The Kaplan-Meier method was used to draw the survival curves. Log rank test was used for univariate analysis, and Cox proportional hazards regression model was used for multivariate analysis. Results The optimal cut-off value of LANR was 18.145, and a low preoperative LANR was significantly correlated with the location of the tumor (p = 0.047). Multivariate analysis showed that tumor differentiation degree (HR:2.357, 95%CI:1.388-4.003,p = 0.002), lymph node metastasis (HR:1.755, 95%CI: 1.115-2.763, p = 0.015), TNM stage (HR:4.686, 95%CI: 2.958-7.425, p < 0.001), preoperative cancer antigen 19 - 9 levels (HR:1.001, 95%CI: 1.000-1.001, p < 0.001) and preoperative LANR (HR:0.221, 95%CI: 0.111-0.441, p < 0.001) were independent risk factors for a poor prognosis in patients undergoing radical resection of PDAC. Conclusion This study found that preoperative LANR can be used to assess the prognosis of radical resection in patients with PDAC; those with low preoperative LANR had a worse outcome.
引用
收藏
页数:8
相关论文
共 38 条
[1]   Preoperative serum albumin is an independent prognostic predictor of survival in ovarian cancer [J].
Asher, V. ;
Lee, J. ;
Bali, A. .
MEDICAL ONCOLOGY, 2012, 29 (03) :2005-2009
[2]   Inflammatory biomarkers and nanotechnology: new insights in pancreatic cancer early detection [J].
Caputo, Damiano ;
Quagliarini, Erica ;
Coppola, Alessandro ;
La Vaccara, Vincenzo ;
Marmiroli, Benedetta ;
Sartori, Barbara ;
Caracciolo, Giulio ;
Pozzi, Daniela .
INTERNATIONAL JOURNAL OF SURGERY, 2023, 109 (10) :2934-2940
[3]   Prognostic value of tumor-associated N1/N2 neutrophil plasticity in patients following radical resection of pancreas ductal adenocarcinoma [J].
Chen, Qiangda ;
Yin, Hanlin ;
Liu, Siyao ;
Shoucair, Sami ;
Ding, Ni ;
Ji, Yuan ;
Zhang, Jicheng ;
Wang, Dansong ;
Kuang, Tiantao ;
Xu, Xuefeng ;
Yu, Jun ;
Wu, Wenchuan ;
Pu, Ning ;
Lou, Wenhui .
JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (12)
[4]   Prognostic role of pretreatment serum albumin in renal cell carcinoma: a systematic review and meta-analysis [J].
Chen, Zhen ;
Shao, Yingjie ;
Wang, Kun ;
Cao, Wei ;
Xiong, Yulong ;
Wu, Rongzu ;
Luo, Shicheng ;
Xu, Xianlin ;
He, Xiaozhou .
ONCOTARGETS AND THERAPY, 2016, 9 :6701-6709
[5]   8th Edition of the AJCC Cancer Staging Manual: Pancreas and Hepatobiliary Cancers [J].
Chun, Yun Shin ;
Pawlik, Timothy M. ;
Vauthey, Jean-Nicolas .
ANNALS OF SURGICAL ONCOLOGY, 2018, 25 (04) :845-847
[6]  
Conroy T., 2023, Ann Oncol
[7]   Prognostic Value of Albumin in Patients With Head and Neck Cancer [J].
Danan, Deepa ;
Shonka, David C., Jr. ;
Selman, Yamil ;
Chow, Zenia ;
Smolkin, Mark E. ;
Jameson, Mark J. .
LARYNGOSCOPE, 2016, 126 (07) :1567-1571
[8]   Mapping the landscape of immunonutrition and cancer research: a comprehensive bibliometric analysis on behalf of NutriOnc Research Group [J].
De Felice, Francesca ;
Cattaneo, Carlo G. ;
Poto, Gianmario E. ;
Antropoli, Carmine ;
Brillantino, Antonio ;
Carbone, Ludovico ;
Brunetti, Oronzo ;
De Luca, Raffaele ;
Desideri, Isacco ;
Incorvaia, Lorena ;
La Mendola, Roberta ;
Marmorino, Federica ;
Parini, Dario ;
Rodriquenz, Maria G. ;
Salvestrini, Viola ;
Sebastiani, Federica ;
Polom, Karol ;
Marano, Luigi .
INTERNATIONAL JOURNAL OF SURGERY, 2024, 110 (01) :395-405
[9]   Immunonutrition and prehabilitation in pancreatic cancer surgery: A new concept in the era of ERAS? and neoadjuvant treatment [J].
De Luca, Raffaele ;
Gianotti, Luca ;
Pedrazzoli, Paolo ;
Brunetti, Oronzo ;
Rizzo, Alessandro ;
Sandini, Marta ;
Paiella, Salvatore ;
Pecorelli, Nicolo ;
Pugliese, Luigi ;
Pietrabissa, Andrea ;
Zerbi, Alessandro ;
Salvia, Roberto ;
Boggi, Ugo ;
Casirati, Amanda ;
Falconi, Massimo ;
Caccialanza, Riccardo .
EJSO, 2023, 49 (03) :542-549
[10]   Preoperative/Neoadjuvant Therapy in Pancreatic Cancer: A Systematic Review and Meta-analysis of Response and Resection Percentages [J].
Gillen, Sonja ;
Schuster, Tibor ;
zum Bueschenfelde, Christian Meyer ;
Friess, Helmut ;
Kleeff, Joerg .
PLOS MEDICINE, 2010, 7 (04)